ALLFLEX UK GROUP LIMITED
Get an alert when ALLFLEX UK GROUP LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-12-16 (in 7mo)
Last made up 2025-12-02
Watchouts
None on the register
Cash
£140K
-1.2% vs 2023
Net assets
£7M
-14.9% vs 2023
Employees
84
-6.7% vs 2023
Profit before tax
-£1M
-216.8% vs 2023
Name history
Renamed 2 times since incorporation
- ALLFLEX UK GROUP LIMITED 2016-04-01 → present
- RITCHEY LIMITED 2010-09-29 → 2016-04-01
- IMCO (142010) LIMITED 2010-07-29 → 2010-09-29
Net assets
2-year trend · vs Basic Materials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £13,525,724 | £11,008,158 | |
| Operating profit | -£644,150 | -£1,516,700 | |
| Profit before tax | -£425,968 | -£1,349,322 | |
| Net profit | -£474,033 | -£1,176,346 | |
| Cash | £142,006 | £140,262 | |
| Total assets less current liabilities | £7,921,032 | £6,744,686 | |
| Net assets | £7,921,032 | £6,744,686 | |
| Equity | £7,921,032 | £6,744,686 | |
| Average employees | 90 | 84 | |
| Wages | £5,181,318 | £5,286,093 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -4.8% | -13.8% | |
| Net margin | -3.5% | -10.7% | |
| Return on capital employed | -8.1% | -22.5% | |
| Gearing (liabilities / total assets) | 48.0% | 40.8% | |
| Current ratio | 1.57x | 1.71x | |
| Interest cover | -23.16x | -102.39x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. As part of those considerations, the directors have obtained written confirmation from its Intermediate Holding Company MSD International BV, confirming support to enable the company to meet its liabilities when they fall due for a period of at least 12 months from the date of approval of the financial statements.”
Significant events
- “Allflex UK Group Limited continues to commercially integrate with the wider MSD Animal Health business, since the acquisition in 2019. As part of the commercial integration the Livestock Monitoring Business Unit was sold to another group undertaking MSD Animal Health UK Limited (100% subsidiary of Merck & Co Inc), on 03 May 2022 for a price of £918,482.”
- “The remaining Livestock Monitoring business that was not part of the sale to MSD Animal Health in 2022 due to the timing of the new product implantation which relates to these products, these new were sold to the below subsidiaries of Merck & Co Inc in April 2024 at book value: MSD Animal Health £735,551 Intervet International B.V £210,507 Total £946,058.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GRUEN, Jeffrey Adam | Director | 2024-04-17 | Feb 1980 | American |
| SPEERS, Andrew James | Director | 2024-04-17 | Oct 1982 | British |
| WARBURTON, Rhys | Director | 2024-04-17 | Aug 1992 | British |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALLAIN, Louis-Marie | Secretary | 2012-10-31 | 2019-07-16 |
| ANDERSON, Ian | Director | 2020-06-23 | 2024-04-17 |
| BATCHELOR, Robin Douglas Lindsay | Director | 2012-10-31 | 2013-02-28 |
| CUERDEN, Simon Paul | Director | 2010-07-29 | 2010-08-12 |
| HADWIN, Ian Rex | Director | 2010-08-12 | 2012-10-31 |
| MUIR, Gregory John | Director | 2010-08-12 | 2012-10-31 |
| MUSGRAVE, John Ashley | Director | 2013-03-01 | 2020-06-23 |
| MYERS, Nigel Stefan | Director | 2013-03-01 | 2015-07-13 |
| PARKER, Kevin David | Director | 2013-03-01 | 2021-04-20 |
| SHEPPY, Charles Norman | Director | 2019-04-12 | 2024-04-17 |
| THORNE, Oliver George | Director | 2021-04-20 | 2024-04-17 |
| THROOP, Emily Dunn | Director | 2019-07-16 | 2024-04-17 |
| WAMBERGUE, Gregoire Claude Jacques | Director | 2013-07-24 | 2019-04-12 |
| WARD, Stuart Clive | Director | 2013-07-24 | 2017-12-13 |
| IMCO DIRECTOR LIMITED | Corporate Director | 2010-07-29 | 2010-08-12 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Merck & Co., Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-04-19 | Active |
| Mr Louis-Marie Allain | Individual | Voting 25–50%, Appoints directors, right-to-appoint-and-remove-directors-as-trust, right-to-appoint-and-remove-directors-as-firm, Significant influence, significant-influence-or-control-as-trust, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2019-07-16 |
| Mr Stuart Clive Ward | Individual | Voting 25–50%, Appoints directors, right-to-appoint-and-remove-directors-as-trust, right-to-appoint-and-remove-directors-as-firm, Significant influence, significant-influence-or-control-as-trust, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2017-12-13 |
| Mr Gregoire Claude Jacques Wambergue | Individual | Voting 25–50%, Appoints directors, right-to-appoint-and-remove-directors-as-trust, right-to-appoint-and-remove-directors-as-firm, Significant influence, significant-influence-or-control-as-trust, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2016-04-06 |
| Mr Kevin David Parker | Individual | Voting 25–50%, Appoints directors, right-to-appoint-and-remove-directors-as-trust, right-to-appoint-and-remove-directors-as-firm, Significant influence, significant-influence-or-control-as-trust, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2016-04-06 |
| Merko Acquisition (Belgique) | Corporate entity | Shares 75–100% | 2016-04-06 | Ceased 2016-04-06 |
| Mr John Ashley Musgrave | Individual | Voting 25–50%, Appoints directors, right-to-appoint-and-remove-directors-as-trust, right-to-appoint-and-remove-directors-as-firm, Significant influence, significant-influence-or-control-as-trust, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2016-04-06 |
Filing timeline
Last 20 of 93 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-05 | AA | accounts | Accounts with accounts type full | |
| 2025-12-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-28 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-12-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-01 | AA | accounts | Accounts with accounts type full | |
| 2024-05-22 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-22 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-22 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-22 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-22 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-22 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-22 | AP01 | officers | Appoint person director company with name date | |
| 2023-12-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-29 | AA | accounts | Accounts with accounts type full | |
| 2023-01-04 | AA | accounts | Accounts with accounts type full | |
| 2022-12-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-21 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2021-12-29 | AA | accounts | Accounts with accounts type full | |
| 2021-12-15 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-18.6%
£13,525,724 £11,008,158
-
Cash
-1.2%
£142,006 £140,262
-
Net assets
-14.9%
£7,921,032 £6,744,686
-
Employees
-6.7%
90 84
-
Operating profit
-135.5%
-£644,150 -£1,516,700
-
Profit before tax
-216.8%
-£425,968 -£1,349,322
-
Wages
+2%
£5,181,318 £5,286,093
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers